Jerrold B. Grossman

CIK: 0001542519

Transaction Breakdown

Open Market Buys (P)3 (42.9%)

High conviction signal

Open Market Sales (S)1 (14.3%)

Position reduction

Option Exercises (M)1 (14.3%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ADMA

ADMA BIOLOGICS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

ADMA
ADMA BIOLOGICS, INC.
May 27, 2026
Purchase(P)
Direct
6.4K shares at avg. $7.91$51K
ADMA
ADMA BIOLOGICS, INC.
May 12, 2026
Purchase(P)
Direct
12.5K shares at avg. $8.01$100K
ADMA
ADMA BIOLOGICS, INC.
May 11, 2026
Purchase(P)
Direct
12.5K shares at avg. $8.01$100K
ADMA
ADMA BIOLOGICS, INC.
Feb 9, 2026
Award(A)
Direct
10.7K shares-
ADMA
ADMA BIOLOGICS, INC.
Jun 9, 2025
Exercise(M)
Direct
10K shares at avg. $5.00$50K
ADMA
ADMA BIOLOGICS, INC.
Jun 9, 2025
Sale(S)
Direct
10K shares at avg. $21.31$213K
ADMA
ADMA BIOLOGICS, INC.
Feb 19, 2025
Award(A)
Direct
10.9K shares-

		Type	Shares	Price		Ownership
May 27, 2026	ADMA ADMA BIOLOGICS, INC.	Purchase(P)	6,400	$7.91	$50,624	Direct
May 12, 2026	ADMA ADMA BIOLOGICS, INC.	Purchase(P)	12,500	$8.01	$100,125	Direct
May 11, 2026	ADMA ADMA BIOLOGICS, INC.	Purchase(P)	12,500	$8.01	$100,125	Direct
Feb 9, 2026	ADMA ADMA BIOLOGICS, INC.	Award(A)	10,690	-	$0	Direct
Jun 9, 2025	ADMA ADMA BIOLOGICS, INC.	Exercise(M)	10,000	$5.00	$50,000	Direct
Jun 9, 2025	ADMA ADMA BIOLOGICS, INC.	Sale(S)	10,000	$21.31	$213,100	Direct
Feb 19, 2025	ADMA ADMA BIOLOGICS, INC.	Award(A)	10,889	-	-	Direct

1-7 of 7 transactions

About Grossman Jerrold B

Grossman Jerrold B (SEC CIK 0001542519) files insider reports with the SEC as Director of ADMA BIOLOGICS, INC. (ADMA).

Signal8 holds 6 ownership filings by Grossman Jerrold B, all Form 4s, filed between Feb 21, 2025 and May 28, 2026. Those filings report 7 transactions, from Feb 19, 2025 to May 27, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Grossman Jerrold B's filings is in RAMSEY, NJ.

Recent filings by Grossman Jerrold B

May 27, 2026: Open-market purchase of ADMA shares (Form 4, code P).
May 12, 2026: Open-market purchase of ADMA shares (Form 4, code P).
May 11, 2026: Open-market purchase of ADMA shares (Form 4, code P).
Feb 9, 2026: Grant or award of ADMA shares (Form 4, code A).
Jun 9, 2025: Option exercise of ADMA shares (Form 4, code M).

Other insiders filing for ADMA BIOLOGICS, INC. (ADMA)

Kestenberg-Messina Kaitlin M., COO and SVP, Compliance
Kohler Terry, CFO and Treasurer
Guiheen Lawrence P., Director
Grossman Adam S, President and CEO
ELMS STEVE, Director
Tade Brad L., CFO and Treasurer

How to read Form 4 transaction codes